413 related articles for article (PubMed ID: 19198578)
1. Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report.
Rahier JF; Rahier J; Leclercq I; Geubel AP
Acta Gastroenterol Belg; 2008; 71(3):318-20. PubMed ID: 19198578
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin-induced prolonged cholestasis with bile duct damage.
Merli M; Bragazzi MC; Giubilo F; Callea F; Attili AF; Alvaro D
Clin Drug Investig; 2010; 30(3):205-9. PubMed ID: 20155993
[TBL] [Abstract][Full Text] [Related]
3. [Acute cholestatic hepatitis after atorvastatin reintroduction].
de Castro ML; Hermo JA; Baz A; de Luaces C; Pérez R; Clofent J
Gastroenterol Hepatol; 2006 Jan; 29(1):21-4. PubMed ID: 16393626
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus. Grupo Lupus Virgen de las Nieves.
Jiménez-Alonso J; Osorio JM; Gutiérrez-Cabello F; López de la Osa A; León L; Mediavilla García JD
Arch Intern Med; 1999 Aug 9-23; 159(15):1811-2. PubMed ID: 10448788
[No Abstract] [Full Text] [Related]
5. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.
Björnsson E; Jacobsen EI; Kalaitzakis E
J Hepatol; 2012 Feb; 56(2):374-80. PubMed ID: 21889469
[TBL] [Abstract][Full Text] [Related]
6. Rhabdomyolysis with concurrent atorvastatin and diltiazem.
Lewin JJ; Nappi JM; Taylor MH
Ann Pharmacother; 2002 Oct; 36(10):1546-9. PubMed ID: 12243603
[TBL] [Abstract][Full Text] [Related]
7. Acute cholestatic hepatitis after reinitiating treatment with atorvastatin.
Ridruejo E; Mandó OG
J Hepatol; 2002 Jul; 37(1):165-6. PubMed ID: 12076881
[No Abstract] [Full Text] [Related]
8. Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin.
Nakad A; Bataille L; Hamoir V; Sempoux C; Horsmans Y
Lancet; 1999 May; 353(9166):1763-4. PubMed ID: 10347994
[No Abstract] [Full Text] [Related]
9. Atorvastatin associated liver disease.
Clarke AT; Mills PR
Dig Liver Dis; 2006 Oct; 38(10):772-7. PubMed ID: 16777499
[TBL] [Abstract][Full Text] [Related]
10. Cholestatic liver dysfunction.
Wierzbicki AS; Crook MA
Lancet; 1999 Sep; 354(9182):954. PubMed ID: 10489985
[No Abstract] [Full Text] [Related]
11. Severe hepatic injury associated with different statins in patients with chronic liver disease: a nationwide population-based cohort study.
Chang CH; Chang YC; Lee YC; Liu YC; Chuang LM; Lin JW
J Gastroenterol Hepatol; 2015 Jan; 30(1):155-62. PubMed ID: 25041076
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune hepatitis revealed by atorvastatin.
Pelli N; Setti M; Ceppa P; Toncini C; Indiveri F
Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):921-4. PubMed ID: 12867804
[TBL] [Abstract][Full Text] [Related]
13. Acute cholestatic hepatitis associated with pravastatin.
Hartleb M; Rymarczyk G; Januszewski K
Am J Gastroenterol; 1999 May; 94(5):1388-90. PubMed ID: 10235223
[TBL] [Abstract][Full Text] [Related]
14. Cholestatic jaundice induced by atorvastatin: a possible association with antimitochondrial antibodies.
Minha S; Golzman G; Adar I; Rapoport M
Isr Med Assoc J; 2009 Jul; 11(7):440-1. PubMed ID: 19911499
[No Abstract] [Full Text] [Related]
15. Drug-induced liver injury associated with statins.
Russo MW; Scobey M; Bonkovsky HL
Semin Liver Dis; 2009 Nov; 29(4):412-22. PubMed ID: 19826975
[TBL] [Abstract][Full Text] [Related]
16. Acute hepatic injury with atorvastatin: an unusual occurrence.
Vishwakarma P; Nehra R; Kumar A
Indian J Pharmacol; 2014; 46(3):343-4. PubMed ID: 24987187
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
18. Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients.
Newman C; Tsai J; Szarek M; Luo D; Gibson E
Am J Cardiol; 2006 Jan; 97(1):61-7. PubMed ID: 16377285
[TBL] [Abstract][Full Text] [Related]
19. Tetracycline-induced bile duct paucity and prolonged cholestasis.
Hunt CM; Washington K
Gastroenterology; 1994 Dec; 107(6):1844-7. PubMed ID: 7958700
[TBL] [Abstract][Full Text] [Related]
20. [Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)].
Gressier L; Pruvost-Balland C; Dubertret L; Viguier M
Ann Dermatol Venereol; 2009 Jan; 136(1):50-3. PubMed ID: 19171231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
